Literature DB >> 9700924

Deciphering the fluorescence signature of daunomycin and doxorubicin.

K K Karukstis1, E H Thompson, J A Whiles, R J Rosenfeld.   

Abstract

The fluorescence characteristics of daunomycin (DNM), doxorubicin (DXR), and other anthracycline drugs are often used to monitor localization of the drug within lipid bilayers and liposomal delivery systems and to assess interaction of the drug with DNA and other macromolecules. However, the binding of DNM and DXR to proteins and membrane systems has been observed to exhibit variable effects on the anthracycline's fluorescence. We have delineated the spectroscopic response of DXR and DNM to their surroundings in several systems, including solvents of differing dielectric constant, aqueous solutions of varying pH or fluorophore concentration, and the reverse micellar system of AOT/heptane/water with a range of doxorubicin concentrations. We have observed that the ratio of fluorescence intestinal at the two principal lambda max values shows a parabolic dependence on solvent dielectric constant, i.e. inverted solvatochromism. This behavior has been overlooked by previous investigators and, together with the appearance of a long-wavelength band near 630 nm in solvents of low dielectric strength (also previously not reported), is key to understanding the partitioning of anthracyclines in membrane systems as well as resolving the conflicting interpretation of data in the literature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700924     DOI: 10.1016/s0301-4622(98)00150-1

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  40 in total

1.  Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

Authors:  U Beyer; B Rothern-Rutishauser; C Unger; H Wunderli-Allenspach; F Kratz
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

Authors:  V Berezowski; C Landry; S Lundquist; L Dehouck; R Cecchelli; M P Dehouck; L Fenart
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

3.  Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors.

Authors:  Marjorie Carlson; Adrienne L Watson; Leah Anderson; David A Largaespada; Paolo P Provenzano
Journal:  J Biomed Opt       Date:  2017-11       Impact factor: 3.170

4.  Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization.

Authors:  Jonathan K Pokorski; Kurt Breitenkamp; Lars O Liepold; Shefah Qazi; M G Finn
Journal:  J Am Chem Soc       Date:  2011-05-31       Impact factor: 15.419

5.  Differential detachment of intact and viable cells of different sizes using laser-induced microbubbles.

Authors:  Wanyoung Lim; Seungjin Lee; Sungsu Park; Hyoung Won Baac
Journal:  Biomed Opt Express       Date:  2019-09-04       Impact factor: 3.732

6.  A Fluorescence Study of the Interaction of Anticancer Drug Molecule Doxorubicin Hydrochloride in Pluronic P123 and F127 Micelles.

Authors:  Sagar Kumar Behera; Maneesha Esther Mohanty; Monalisa Mohapatra
Journal:  J Fluoresc       Date:  2020-10-10       Impact factor: 2.217

7.  Elucidation of the binding properties of a photosensitizer to salmon sperm DNA and its photobleaching processes by spectroscopic methods.

Authors:  Lei Zhang; Guo-Qing Tang
Journal:  J Fluoresc       Date:  2012-11-17       Impact factor: 2.217

8.  Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity.

Authors:  Peng Guo; Jin-Oh You; Jiang Yang; Marsha A Moses; Debra T Auguste
Journal:  Biomaterials       Date:  2012-08-09       Impact factor: 12.479

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.

Authors:  G Munkácsy; R Abdul-Ghani; Z Mihály; B Tegze; O Tchernitsa; P Surowiak; R Schäfer; B Györffy
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.